BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the BCR-ABL; SB cohort was the only group to manifest a continuum of CML progression, with tumors in the intermediate accelerated phase (10%) and blast crisis phase (5%) (104).